Agios to Present New Clinical Data from its IDH Programs at ASCO
May 17, 2017 21:30 pm UTC| Business
– Updated Data from IDHIFA® (Enasidenib) Phase 1 Trial in IDH2m R/R AML to be Presented in Oral Presentation; Abstract Selected for Best of ASCO Program – – First Data from the Ivosidenib (AG-120) Phase 1...
May 17, 2017 21:17 pm UTC| Business
CAMBRIDGE, Mass., May 17, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported interim data from the Phase 1 study of DKN-01 in...
May 17, 2017 21:16 pm UTC| Business
BOSTON, May 17, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter,...
May 17, 2017 21:16 pm UTC| Business
BOSTON, May 17, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter,...
May 17, 2017 21:16 pm UTC| Business
NEW YORK, May 17, 2017 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Neurotrope, Inc. (“Neurotrope”) (NASDAQ:NTRP)...
May 17, 2017 21:16 pm UTC| Business
NEW YORK, May 17, 2017 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Neurotrope, Inc. (“Neurotrope”) (NASDAQ:NTRP)...
Mitel Reports Voting Results from 2017 Annual Meeting of Shareholders
May 17, 2017 21:10 pm UTC| Business
OTTAWA, May 17, 2017 -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in enterprise communications, announced at its Annual Meeting of Shareholders held on May 15, 2017 the election of 8 nominees proposed for its...